The Human Upgrade: Biohacking for Longevity & Performance

This Popular Fat Loss Shortcut Destroys Your Youth : 1437

87 snips
Mar 24, 2026
Hannah Kleinfeld, co-founder and COO of OMNi-BiOTiC US and microbiome expert trained at Yale and Harvard, shares clinical probiotic research and gut-brain insights. She discusses how GLP-1 drugs can cause secondary dysbiosis, why many probiotics fail in stomach acid, and how microbiome shifts affect sleep, HRV, inflammation, hormones, and weight.
Ask episode
AI Snips
Chapters
Books
Transcript
Episode notes
ANECDOTE

Dave's Rapid Recovery Using AB10 After Surgery

  • Dave used Omnibiotic AB10 after surgery antibiotics and saw GI normalcy within days.
  • He credits the AB10 post‑antibiotic formula for rapid recovery from antibiotic‑associated disruption.
INSIGHT

Gut Inflammation Lowers HRV Through The Vagus Nerve

  • The gut sends threat signals to the brain via the vagus nerve and chronic gut inflammation suppresses HRV and parasympathetic activity.
  • Hannah cites a study where Omnibiotic Stress Release improved morning vagal tone and sleep within four weeks.
ADVICE

Use Targeted Probiotics With GLP‑1 Therapy

  • Combining lower GLP‑1 dosing with targeted probiotics reduced GI side effects and secondary dysbiosis while matching weight‑loss results of higher doses in European research.
  • Use gut support during GLP‑1 therapy to improve adherence and protect long‑term gut health.
Get the Snipd Podcast app to discover more snips from this episode
Get the app